These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8134380)

  • 1. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin.
    Block TM; Lu X; Platt FM; Foster GR; Gerlich WH; Blumberg BS; Dwek RA
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2235-9. PubMed ID: 8134380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.
    Simsek E; Lu X; Ouzounov S; Block TM; Mehta AS
    Antivir Chem Chemother; 2006; 17(5):259-67. PubMed ID: 17176630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
    Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
    Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
    Lu X; Mehta A; Dwek R; Butters T; Block T
    Virology; 1995 Nov; 213(2):660-5. PubMed ID: 7491790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
    Dai XQ; Cai WT; Wu X; Chen Y; Han FM
    Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences.
    Mabit H; Dubanchet S; Capel F; Dauguet C; Petit MA
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2681-9. PubMed ID: 7931154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for dual effects of DNA-reactive bile acid derivatives (Bamets) on hepatitis B virus life cycle in an in vitro replicative system.
    Romero MR; Martinez-Diez MC; Larena MG; Macias RI; Dominguez M; Garcia-Monzon C; Serrano MA; Marin JJ
    Antivir Chem Chemother; 2002 Nov; 13(6):371-80. PubMed ID: 12718409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
    Hu K; Huang Y; Mu J; Cheng Z; Zhu X
    Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.
    Weiss L; Kekulè AS; Jakubowski U; Bürgelt E; Hofschneider PH
    Virology; 1996 Feb; 216(1):214-8. PubMed ID: 8614990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.
    Dougherty AM; Guo H; Westby G; Liu Y; Simsek E; Guo JT; Mehta A; Norton P; Gu B; Block T; Cuconati A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4427-37. PubMed ID: 17875990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications.
    Mehta A; Carrouée S; Conyers B; Jordan R; Butters T; Dwek RA; Block TM
    Hepatology; 2001 Jun; 33(6):1488-95. PubMed ID: 11391538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hepatocellular carcinoma cell line producing mature hepatitis B viral particles.
    Fellig Y; Almogy G; Galun E; Ketzinel-Gilad M
    Biochem Biophys Res Commun; 2004 Aug; 321(2):269-74. PubMed ID: 15358171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line.
    Lu X; Block TM; Gerlich WH
    J Virol; 1996 Apr; 70(4):2277-85. PubMed ID: 8642654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound.
    Warner N; Locarnini S
    Hepatology; 2008 Jul; 48(1):88-98. PubMed ID: 18537180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
    Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
    World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy.
    Shirvani-Dastgerdi E; Winer BY; Celià-Terrassa T; Kang Y; Tabernero D; Yagmur E; Rodríguez-Frías F; Gregori J; Luedde T; Trautwein C; Ploss A; Tacke F
    J Hepatol; 2017 Aug; 67(2):246-254. PubMed ID: 28392234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.